Shree Ganesh Remedies Strengthens Board with New Independent Director and Reappoints Cost Auditor
Shree Ganesh Remedies Limited has appointed Ms. Shruti Sohane as an Additional Director (Non-Executive, Independent) for a five-year term, effective August 08, 2025. The company has also reappointed M/s. M. I. Prajapati & Associates as Cost Auditor for FY 2025-2026 with a remuneration of Rs. 55,000 plus taxes. Additional decisions include appointing a scrutinizer for e-voting and approving the 30th AGM notice and Directors' Report.
Shree Ganesh Remedies Limited received a GST summons from the Superintendent of Central GST and Central Excise Unit, Vadodara, alleging violations related to expired stock in a company warehouse. The summons involves a potential GST liability of approximately Rs. 88.61 Lacs. The company, supported by legal and tax counsel, plans to contest the allegations, believing them to be untenable under existing law and judicial precedents. They intend to file an appeal before the appellate authority. The investigation is currently at a preliminary stage, and the company has informed BSE Limited about the summons in compliance with SEBI regulations.
19May 25
Shree Ganesh Remedies Reports Mixed Q4 Results with Profit Growth and Revenue Decline
Shree Ganesh Remedies' Q4 results show a mixed performance. Net profit increased to ₹66.00 crore from ₹54.00 crore in Q3, but decreased from ₹126.00 crore year-over-year. Revenue declined to ₹244.00 crore from ₹373.00 crore in the previous year. EBITDA fell to ₹9.90 crore from ₹16.90 crore, with EBITDA margin dropping to 40.44% from 45.40% year-over-year.